Search results
TauRx seeks UK MHRA approval for Alzheimer’s treatment
Pharmaceutical Technology· 3 days agoTau aggregation, a key factor in Alzheimer's, correlates with cognitive decline severity and brain...
Japan's Eisai developing dementia drug for US market - ET HealthWorld | Pharma
The Economic Times· 4 days agoEisai already has a dementia drug on the U.S. market called Leqembi, co-developed with U.S. peer...
Annovis stock swells after Phase III Parkinson’s subgroup success
Clinical Trials Arena· 14 hours agoBuntanetap showed a statistical improvement in several disease-related scores in certain Parkinson’s...
Lilly drug for Alzheimer’s approved by FDA
BioPharma Dive· 2 days agoThe drug, which Lilly will sell as Kinsunla, carries a warning for the risk of a certain kind of imaging abnormality that can be serious in rare cases.